Form D — Illexcor Therapeutics, Inc.
0002132799-26-000001 · filed 2026-05-08
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $69,000,000
- Total sold
- $13,000,000
- Minimum investment
- $1,000,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Illexcor Therapeutics, Inc.
- CIK
- 2132799
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 11924 Evening Loop
HENRICO, VA 23233 - Phone
- (650) 935 5772
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew N Fleischman · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Timothy E Ladin · Executive OfficerDorset, VT Find on LinkedIn ↗
-
Giovanni Mariggi · DirectorGeneva, V8 Find on LinkedIn ↗
-
Maneka Mirchandaney · DirectorNew York, NY Find on LinkedIn ↗
-
Ted Love · DirectorSonoma, CA Find on LinkedIn ↗
View original on SEC EDGAR.